Cargando…
Safe liver resection following chemotherapy for colorectal metastases is a matter of timing
Neoadjuvant chemotherapy (NC) can improve the resectability of hepatic colorectal metastases (CRM). However, there is concern regarding its impact on operative risk. We reviewed 750 consecutive liver resections performed for CRM in a single unit (1996–2005) to evaluate whether NC affected morbidity...
Autores principales: | Welsh, F K S, Tilney, H S, Tekkis, P P, John, T G, Rees, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360122/ https://www.ncbi.nlm.nih.gov/pubmed/17353923 http://dx.doi.org/10.1038/sj.bjc.6603670 |
Ejemplares similares
-
A proposed new method for assessing the pathological response to chemotherapy in resected colorectal liver metastases
por: Sebagh, M, et al.
Publicado: (2014) -
C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases
por: Wong, V K H, et al.
Publicado: (2007) -
Initial Experiences of Simultaneous Laparoscopic Resection of Colorectal Cancer and Liver Metastases
por: Hoekstra, L. T., et al.
Publicado: (2012) -
Resection of colorectal liver metastases following neoadjuvant chemotherapy
por: Chiappa, A, et al.
Publicado: (2007) -
FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer
por: Bertolini, F, et al.
Publicado: (2011)